3D Bioprinting Industry Growth, Upcoming Trends and Insights By 2023

1. 3D Bioprinting Industry Growth, Upcoming Trends and Insights By 2023 3D Bioprinting Market Analysis: Global 3D Bioprinting Industry is projected to reach USD 1,923.02 Million at a CAGR of 24.5% over the forecast period 2018 to 2023. Also, rising occurrences of organ failure owing to accidents, diseases, and old age have created a massive gap for the functioning of organs. The emergence of 3D bioprinting can fill-in the gap by producing them on a massive scale. 3D bioprinting leverages 3D printing technology for the formation of biomedical components using biomaterials to imitate natural tissues and organs. Rising Cases of Organ Failures Expected to Motivate Growth Trajectory of 3D Bioprinting Market It is reported that the growing demand for organ transplantation is expected to push the growth of the 3D Bioprinting Market. The cost-effective nature of the technology is expected to drive the market demand as well. Opportunities related to the manufacturing of pills for the pharmaceutical sector and for producing prosthetics and implants is anticipated to augment the market too. The rising investment for R&D activities is expected to broaden the potential of the technology and subsequently the market growth. 3D Bioprinting Market Regional Analysis: The regional assessment of the 3D bioprinting market covers a detailed analysis of the four regional segments along with an exhaustive country-level analysis. The regions included in the analysis are - Americas, Asia Pacific (APAC), Europe, and the Middle East & Africa (MEA). America • North America • US • Canada • South America Europe • Western Europe • Germany • UK • France • Italy • Spain

2. • Rest Of Western Europe • Eastern Europe Asia Pacific • Japan • China • India • Australia • Republic Of Korea • Rest Of Asia Pacific Middle East & Africa • United Arab Emirates • Saudi Arabia • Oman • Kuwait • Qatar • Rest Of Middle East & Africa 3D Bioprinting Market Competitive Dashboard: Top companies operating in the global 3D bioprinting market are • • EnvisionTEC GmbH (Germany) • Allevi (U.S.) • REGENHU Ltd. (Switzerland) • Aspect Biosystems Ltd. (Canada) • Cyfuse Biomedical K.K. (Japan) • Poietis (France) Cellink AB (Sweden) • Stratasys Ltd. (U.S.) • Organovo Holdings Inc. (U.S.) • FUJIFILM Wako Automation Corporation (U.S.)

3. • Regenovo Biotechnology Co. Ltd. (China) • Nano3D Biosciences Inc. (U.S.) 3D Bioprinting Market Segmentation: The segmental analysis of the 3D bioprinting market, on the basis of •material •covers extracellular matrices •living cells •hydrogels Based on technology, the segments of the global 3D bioprinting market are •micro extrusion bioprinting •magnetic 3D bioprinting •inkjet 3D bioprinting •laser-assisted bioprinting The major applications-wise segments studied in the assessment of 3D bioprinting market are research and clinical applications. The end-users identified in this MRFR report are research organizations & academic institutes, and pharmaceutical & biotechnology companies. Brows More Healthcare Related Research Reports at: Patient Temperature Monitoring Market Research Report - Forecast to 2023 | MRFR Hematology Diagnostics Market Research Report –Global Forecast to 2023| MRFR ENT Devices Market Overview, Growth Analysis, Industry Size and Forecast to 2023 About Market Research Future: At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Contact: Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune - 411028

4. Maharashtra, India Phone: +16468459312 Email: sales@marketresearchfuture.com